69.50p-1.00 (-1.42%)12 Aug 2022, 17:06
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Angle PLC Fundamentals

Company NameAngle PLCLast Updated2022-08-12
IndustryDiagnostics & ResearchSectorHealthcare
Shares in Issue260.491 mMarket Cap£181.04 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.07EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.0494Debt Equity Ratio0.0450
Asset Equity Ratio1.1732Cash Equity Ratio0.7895
Quick Ratio6.7290Current Ratio8.01
Price To Book Value4.4883ROCE0

Angle PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Angle PLC Company Financials

Tangible Assets£4.38 m£2.41 m£1.35 m
Intangible Assets£3.57 m£3.71 m£4.15 m
Total Fixed Assets£7.95 m£6.12 m£5.50 m
Stocks£1.75 m£742,000.00£988,000.00
Debtors£1.21 m£1.36 m£942,000.00
Cash & Equivalents£31.84 m£28.62 m£11.01 m
Other Assets000
Total Assets£47.31 m£39.05 m£20.34 m
Creditors within 1 year£4.91 m£3.78 m£3.68 m
Creditors after 1 year£2.07 m£928,000.000
Other Liabilities000
Total Liabilities£6.99 m£4.71 m£3.68 m
Net assets£40.33 m£34.34 m£16.65 m
Called up share capital£23.51 m£21.54 m£14.35 m
Share Premium£99.41 m£81.53 m£53.27 m
Profit / Loss-£17.36 m-£13.74 m-£10.87 m
Other Equity£40.33 m£34.34 m£16.65 m
Preference & Minorities000
Total Capital Employed£40.33 m£34.34 m£16.65 m
Debt Ratio£0.04£0.030
Assets / Equity1.17321.17321.1732
Cash / Equity0.78950.78950.7895
Cash Flow202120202019
Cash from operating activities-£14.01 m-£7.85 m-£7.31 m
Cashflow before financing£4.98 m£10.29 m£4.68 m
Increase in Cash£19.75 m£8.33 m£3.36 m
Turnover£1.01 m£762,000.00£678,000.00
Cost of sales£302,000.00£165,000.00£155,000.00
Gross Profit£711,000.00£597,000.00£523,000.00
Operating Profit-£17.23 m-£13.73 m-£10.90 m
Pre-Tax profit-£17.36 m-£13.74 m-£10.87 m

Angle PLC Company Background

ActivitiesANGLE PLC is active in the healthcare sector in the United Kingdom. It is a medical diagnostic company specializing in the development of pioneering products in cancer diagnostics. Its patented Parsortix technology can potentially treat and diagnose various forms of cancer. The Parsortix system can capture and harvest CTCs from patient blood. Its geographical segments include Europe and North America, from which most of its revenue is generated from Europe.
Latest Interim Date30 Sep 2021
Latest Fiscal Year End Date28 Apr 2022

Angle PLC Directors

2022-06-06Mr. Garth Robert SelveyNon-Executive Director,Chairman
2022-07-19Mr. Andrew David William NewlandExecutive Director,Chief Executive Officer
2014-09-30Mr. David William Quysner CBENon-Executive Director
2022-07-19Mr. Ian Francis GriffithsExecutive Director,Finance Director and Company Secretary
2022-06-06Mr. Brian HowlettNon-Executive Director
2011-08-09Dr. Hance Fullerton OBE LLDNon-Executive Director,Chairman

Angle PLC Contact Details

Company NameANGLE PLC
Address10 Nugent Road, The Surrey Research Park, Guildford, GU2 7AF
Telephone+44 1483295830

Angle PLC Advisors

Financial PR AdviserFTI Consulting Inc
Phone+44 2037271000
Fax+44 2037271007
Phone0845 057 0700
Fax0845 057 0701
BankNational Westminster Bank PLC
RegistrarCapita Asset Services
Phone+44 8716640300
Fax+44 2086392342
StockbrokerCenkos Securities
Phone+44 2073978900
Fax+44 2073978901
SolicitorPinsent Masons LLP
Phone(020) 7418 7000
Fax(020) 7418 7050
Nominated AdviserCenkos Securities
Phone+44 2073978900
Fax+44 2073978901